Results 501-520 of 1,237,402 for in 'Dáil debates' OR in 'Committee meetings' (speaker:Ciarán Cuffe OR speaker:Marian Harkin OR speaker:Bríd Smith OR speaker:Peadar Tóibín OR speaker:Joe O'Brien OR speaker:Colm Burke OR speaker:Martin Heydon OR speaker:Brendan Smith OR speaker:Pearse Doherty OR speaker:James O'Connor OR speaker:Pádraig Mac Lochlainn OR speaker:Aengus Ó Snodaigh OR speaker:Bernard Durkan OR speaker:Alan Farrell OR speaker:Aodhán Ó Ríordáin OR speaker:James Lawless OR speaker:Aengus Ó Snodaigh01 OR speaker:Joe McHugh OR speaker:Aengus Ó Snodaigh06 OR speaker:Marc MacSharry OR speaker:Frank Feighan OR speaker:Aengus Ó Snodaigh25 OR speaker:Noel Grealish OR speaker:Aengus Ó Snodaigh07 OR speaker:Pádraig O'Sullivan OR speaker:Eoin Ó Broin OR speaker:Aengus Ó Snodaigh30 OR speaker:Aengus Ó Snodaigh12 OR speaker:Kieran O'Donnell OR speaker:Aengus Ó Snodaigh14 OR speaker:Michael Fitzmaurice OR speaker:Aengus Ó Snodaigh31 OR speaker:Dessie Ellis OR speaker:Michael Creed OR speaker:Seán Canney OR speaker:David Cullinane OR speaker:Aengus Ó Snodaigh32 OR speaker:Aengus Ó Snodaigh10 OR speaker:Louise O'Reilly OR speaker:Patrick O'Donovan OR speaker:Charlie McConalogue OR speaker:Michael Ring OR speaker:Michael McGrath OR speaker:Róisín Shortall OR speaker:Michael Lowry OR speaker:Aengus Ó Snodaigh28 OR speaker:Mary Lou McDonald OR speaker:Gino Kenny OR speaker:Ruairi Ó Murchú OR speaker:Seán Ó Fearghaíl OR speaker:Jack Chambers OR speaker:Seán Sherlock OR speaker:Heather Humphreys OR speaker:John Brady OR speaker:James Browne OR speaker:Colm Brophy OR speaker:Brendan Griffin OR speaker:Aengus Ó Snodaigh8 OR speaker:Aengus Ó Snodaigh29 OR speaker:Martin Kenny OR speaker:Rose Conway-Walsh OR speaker:Pat Buckley OR speaker:Robert Troy OR speaker:Stephen Donnelly OR speaker:Peter Burke OR speaker:Matt Carthy)
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Gino Kenny: The committee produced a very comprehensive report based on hearings with witnesses who came before us. It was an interim report, although it may end up being the final report of the committee because there will be a general election in a number of weeks. The report is very progressive. One of the main areas it touches on is repealing the Misuse of Drugs Act. We cannot really discuss...
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Gino Kenny: Thanks for that. The staff here have been fantastic and all the members have been really good about getting that report out.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Gino Kenny: That person will have a criminal record for the rest of his life. It is unbelievable really.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Gino Kenny: Very good. Did Mr. Perth want to come in?
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Gino Kenny: I will call Ms Kelly. I will go around to everybody.
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Gino Kenny: Does Mr. McCann want to come in?
- Committee on Drugs Use: Family and Community: Discussion (24 Oct 2024)
Gino Kenny: I thank Mr. McCann. We will probably end on that positive note. I thank everybody for coming in today and engaging with the committee, Mr. McCarthy, Mr. Collins, Ms Kelly, Mr. Ducque, Mr. Perth, Mr. Whiteley, Mr. D'Arcy and Mr. McCann. Their contributions have been very valuable. I also thank Senator Lynn Ruane. Senator Ruane's contribution over the lifetime of this committee has...
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: I congratulate Deputy Farrell on assuming the role of Chair of the Committee of Public Accounts. I think she will be excellent, and I wish her every success. I thank our witnesses for joining us this morning for what I hope will be an enlightening and helpful discussion on how manage the significant resources that we invest in our health service on the part of our taxpayers. I also thank...
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: For those of us who are far from expert on how exactly it is intended to drive this innovation within the system, is there a unit within the HSE that oversees this process?
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: What sort of expertise exists within that unit?
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: Several hundred.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: How many? Is there a ballpark figure? Is it 200, 300, 500-----
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: Covid gave us an insight into-----
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: -----what exactly is possible.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: Have the people who are leading that change in that unit of 700 people ever contemplated visiting places such as Denmark - maybe they already have - which is not dissimilar to us in terms of its demographics and population? Estonia is a very small, agile country that has been doing extraordinary things in the use of technology for how a citizen interacts with the state. Have we visited...
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: I know this is a difficult question, but in Mr. Gloster's estimation, how far away are we from having an actual workable EHR for every person in this country?
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: If we get it in seven years, I will be happy.
- Public Accounts Committee: Financial Statements 2023: Health Service Executive (24 Oct 2024)
Ciarán Cannon: Go raibh maith agat.